share_log

NextPlat Invests $7 Million in Recapitalization of Progressive Care Inc.

NextPlat Invests $7 Million in Recapitalization of Progressive Care Inc.

NextPlat投資700萬美元對進步護理公司進行資本重組。
Accesswire ·  2022/08/31 08:05

Investment to Accelerate Progressive's Digital Healthcare Transformation and Launch of Global E-Commerce Platform for New Healthcare Products for Domestic and International Markets

投資加速進步公司的數字醫療轉型並推出面向國內外市場的全球醫療保健新產品電子商務平臺

COCONUT GROVE, FL / ACCESSWIRE / August 31, 2022 / NextPlat Corp (NASDAQ:NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider today announced that it has completed a strategic $7 million investment in Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company ("Progressive Care").

佛羅裏達州椰子林/ACCESSWIRE/2022年8月31日/NextPlat Corp(NextPlat:行情)納斯達克:NXPL、NXPLW)(“NextPlat”或“公司”),一家全球電子商務提供商今天宣佈,它已經完成了對進步護理公司(OTCQB:RXMD)的700萬美元戰略投資,該公司是一家個性化醫療服務和技術公司(“進步護理”)。

Under the recapitalization plan, NextPlat Corp, its Executive Chairman and CEO, Charles M. Fernandez, and board member, Rodney Barreto, and certain other investors will invest an aggregate of $8.3 million into Progressive Care. In connection with the recapitalization, NextPlat will purchase 3,000 newly issued Units of Progressive Care valued at $6 million, with each Unit comprised of one share of Progressive Care's Series B Preferred Stock and one Warrant to purchase a share of Series B Preferred Stock. In addition, NextPlat Corp, Messrs. Fernandez and Barreto, and certain other investors will purchase $2.3 million of outstanding convertible debt from an existing holder. In connection with debt purchase, NextPlat Corp and the other purchasers agreed to a fixed conversion price of $0.02 per share of common stock and removal of the blocker. NextPlat Corp and the other purchasers also agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum.

根據資本重組計劃,NextPlat公司及其執行主席兼首席執行官查爾斯·M·費爾南德斯、董事會成員羅德尼·巴雷託和某些其他投資者將向進步護理公司投資總計830萬美元。與資本重組有關,NextPlat將購買3000個新發行的單位,價值600萬美元,每個單位包括一股進步護理公司的B系列優先股和一份購買B系列優先股的認股權證。此外,NextPlat Corp、費爾南德斯和巴雷託以及某些其他投資者將從現有持有者手中購買230萬美元的未償還可轉換債券。在債務購買方面,NextPlat公司和其他買家同意每股普通股0.02美元的固定轉換價格,並取消阻止。NextPlat公司和其他買家還同意將所購債務的年利率從10%降至5%。

NextPlat's management team and select members of its Board of Directors will provide Progressive Care with their market-proven expertise in healthcare and digital technology including the development of new healthcare and lifestyle products to be sold via NextPlat's global e-commerce marketplaces. As part of this transaction, Mr. Fernandez will be appointed as Chairman of Progressive Care replacing Alan Jay Weisberg who will step down from his current positions to assume the new roles of Vice Chairman and CEO. Mr. Barreto will also be joining Progressive Care's board as Vice Chairman. Dawson James Securities Inc. ("Dawson") served as the placement agent for this transaction. Progressive Care intends to utilize a portion of the growth capital to further fund deployment of its digital platforms and the development and sale of new health, fitness, and beauty products.

NextPlat的管理團隊和部分董事會成員將利用他們在醫療保健和數字技術方面經過市場驗證的專業知識,包括開發將通過NextPlat全球電子商務市場銷售的新保健和生活方式產品。作為這項交易的一部分,費爾南德斯先生將被任命為進步護理公司的董事長,接替艾倫·傑伊·魏斯伯格,後者將辭去目前的職位,擔任副董事長兼首席執行官的新角色。巴雷託先生還將加入進步護理公司的董事會,擔任副董事長。道森·詹姆斯證券公司(Dawson James Securities Inc.)是此次交易的配售代理。進步護理打算利用增長資本的一部分,進一步為其數字平臺的部署以及新健康、健身和美容產品的開發和銷售提供資金。

Progressive Care Inc. is a Florida-based technology-centric healthcare organization. It provides prescription pharmaceuticals and contracted pharmacy services directly to consumers, long-term care facilities as well to 340B covered entities in underserved or vulnerable communities in 13 states. Progressive Care also has developed and provides extensive healthcare data management and analytics services in addition to providing virtual healthcare to customers. In 2021, Progressive Care reported annual revenues of approximately $40 million.

進步護理公司是一家總部設在佛羅裏達州的以技術為中心的醫療保健組織。它直接向消費者提供處方藥和簽約藥房服務,向13個州服務不足或脆弱社區的340億覆蓋實體提供長期護理設施。除了向客户提供虛擬醫療保健外,漸進式醫療保健還開發並提供了廣泛的醫療數據管理和分析服務。2021年,漸進式醫療報告的年收入約為4000萬美元。

Over the past 30 years, Mr. Fernandez has successfully identified profitable start-up and dislocation opportunities, and built significant shareholder value, executing both private and public exits. Mr. Fernandez's expertise in technology and healthcare includes co-founding Lakeview Health Systems (acquired by a private equity firm for approximately $70 million) and Continucare Corporation (acquired by Metropolitan Health Networks, Inc. for approximately $400 million) where he served as chairman, president and CEO. He also served as an investor, director, and Chairman of the Audit Committee of IVAX Corporation for nearly a decade prior to its purchase by Teva Pharmaceuticals for $8.7 billion.

在過去的30年裏,費爾南德斯成功地發現了有利可圖的初創企業和脱穎而出的機會,並通過執行私人和公開退出,創造了巨大的股東價值。費爾南德斯先生在技術和醫療保健領域的專長包括共同創立了Lakeview Health Systems(被一傢俬募股權公司以約7,000萬美元收購)和Continucare Corporation(被Metropolitan Health Networks,Inc.以約4億美元收購),在那裏他擔任董事長、總裁和首席執行官。在IVAX公司被Teva製藥公司以87億美元收購之前,他還擔任過董事的投資者和審計委員會主席近十年。

"Progressive Care has built a vibrant and rapidly growing healthcare services and technology company currently serving tens of thousands of customers who rely on its PharmcoRx platform and services every day. As a technology and healthcare entrepreneur, I see tremendous value in Progressive Care's capabilities which is why I am personally investing alongside of NextPlat. I believe we can leverage our expertise, industry know-how and global e-commerce platforms to accelerate their continued growth domestically as well as internationally. As long-term investors, we are committed to harnessing the power of digital technologies including Web3, to capitalize on the ongoing digital transformation of Progressive Care and the entire healthcare industry," said Charles M. Fernandez.

進步醫療已經建立了一家充滿活力和快速增長的醫療服務和技術公司,目前每天為數萬名依賴其PharmcoRx平臺和服務的客户提供服務。作為一名技術和醫療保健企業家,我看到了漸進式醫療的能力的巨大價值,這就是為什麼我個人與NextPlat一起投資。我相信我們可以利用我們的專業知識、行業知識和全球電子商務平臺,加快它們在國內和國際上的持續增長。作為長期投資者,我們致力於利用包括Web3在內的數字技術的力量,利用漸進式醫療和整個醫療行業正在進行的數字化轉型。

Alan Jay Weisberg commented, "Progressive Care has pursued a vision of being able to transform the healthcare industry by creating data-driven tools and technology. Charlie and the team at NextPlat have extensive knowledge and experience in utilizing digital technology and we believe will help Progressive Care build significant value for all stakeholders including patients, payors, practitioners, and investors. We are excited to have this team of industry leaders as our new long-term investors and partners, and look forward to working together advancing our vision for modern healthcare."

Alan Jay Weisberg評論説:“漸進式醫療服務追求的是能夠通過創造數據驅動的工具和技術來改變醫療保健行業的願景。Charlie和NextPlat的團隊在利用數字技術方面擁有豐富的知識和經驗,我們相信這將幫助漸進式醫療服務為包括患者、付款人、從業者和投資者在內的所有利益相關者建立顯著的價值。我們很高興有這個行業領導者團隊作為我們新的長期投資者和合作夥伴,並期待着共同努力,推進我們對現代醫療保健的願景。”

About NextPlat Corp
NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The Company intends to collaborate with businesses, optimizing their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd and Orbital Satcom Corp business units that offer voice, data, tracking, and IoT services to customers worldwide through multiple global storefronts.

關於NextPlat公司
NextPlat是一家全球電子商務平臺公司,旨在利用實體和數字資產的多個高增長行業和市場。該公司打算與企業合作,優化他們在網上、國內和國際銷售商品的能力,並使客户和合作夥伴能夠優化他們的電子商務存在和收入。NextPlat目前通過其Global Telesat Communications Ltd和Orbary Satcom Corp業務部門運營着一個電子商務通信服務部門,這兩個部門通過多個全球店面向全球客户提供語音、數據、跟蹤和物聯網服務。

Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

漸進式護理公司
進步護理公司(場外交易市場代碼:RXMD)通過其子公司,是佛羅裏達州的一家醫療服務組織,提供處方藥、複合藥物、遠程藥房服務、抗逆轉錄病毒藥物銷售、藥物治療管理(MTM)、向長期護理機構供應處方藥以及健康實踐風險管理。

Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch new data-driven tools and services and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

前瞻性陳述
本新聞稿中的某些陳述屬於前瞻性陳述。這些陳述包括公司業務及其任何產品、服務或解決方案的能力和成功。“相信”、“預測”、“項目”、“打算”、“預期”、“計劃”、“應該”、“將會”以及類似的表述和所有非歷史事實的表述都旨在識別前瞻性表述。這些前瞻性陳述涉及並受制於已知和未知的風險、不確定因素和其他因素,包括公司推出新的數據驅動工具和服務的能力以及公司按預期增長和擴張的能力,任何這些因素都可能導致公司無法實現其部分或全部目標或公司之前報告的實際結果、業績(財務或運營),包括此類前瞻性陳述明示或暗示的內容。有關公司以及可能影響前瞻性陳述實現的風險因素的更詳細信息,請參閲公司提交給美國證券交易委員會(以下簡稱“美國證券交易委員會”)的文件,這些文件的副本可從美國證券交易委員會的網站www.sec.gov獲得。本公司不承擔任何義務更新本新聞稿中包含的前瞻性陳述。

Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net

NextPlat公司的媒體和投資者聯繫人:
邁克爾·格里克曼
MWGCO,Inc.
917-397-2272
郵箱:Mike@mwgco.net

SOURCE: NextPlat Corp

資料來源:NextPlat公司


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論